EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

66 hedge funds and large institutions have $14.6M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 28 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$398K
2
+$275K
3
+$208K
4
YIH
Y-Intercept (HK)
Hong Kong
+$114K
5
Verition Fund Management
Verition Fund Management
Connecticut
+$106K

Top Sellers

1
-$1.32M
2
-$486K
3
-$363K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$287K
5
Renaissance Technologies
Renaissance Technologies
New York
-$276K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$2.69K
52
$2.22K
53
$1.1K
54
$1K
55
$1K
56
$909
57
$593
58
$569
59
$408
60
$282
61
$260
62
$245
63
$236
64
$124
65
$4
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4